Global Cardiology Academy - Global Cardiology Academy

Global Cardiology Academy

Welcome to Global
Cardiology Academy

Enhance your cardiology practice with CME and
tools focused on heart health management.

Popular

CME/CE In-Person Event
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
August 29, 2026
Munich
0.75 credits
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Clinician's Roundtable
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
AudioAbstracts
Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
Ryan Quigley
- Ryan Quigley
CME/CE In-Person Event
Translating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
August 30, 2026
Munich
0.75 credits
How Symptoms Shape Caregiver Burden in ATTR-CM
How Symptoms Shape Caregiver Burden in ATTR-CM
AudioAbstracts
How Symptoms Shape Caregiver Burden in ATTR-CM
Ryan Quigley
- Ryan Quigley
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Heart Matters
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Valmiki Maharaj, MD
- Valmiki Maharaj, MD
Closing Diagnostic Gaps in ATTR-CM
Closing Diagnostic Gaps in ATTR-CM
Heart Matters
Closing Diagnostic Gaps in ATTR-CM
Ronald Witteles, MD
- Ronald Witteles, MD
Understanding Real-World Testing Patterns in ATTR-CM
Understanding Real-World Testing Patterns in ATTR-CM
On the Frontlines of ATTR-CM
Understanding Real-World Testing Patterns in ATTR-CM
Steve Jackson, PharmD; Ronald Witteles, MD
- Steve Jackson, PharmD
- Ronald Witteles, MD

Programs

Familial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
Familial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
On the Frontlines of Familial Chylomicronemia Syndrome
Familial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
Steve Jackson, PharmD; Nivedita Patni, MD
- Steve Jackson, PharmD
- Nivedita Patni, MD
Hypertension in Women: Cardiovascular Risk Across the Lifespan
Hypertension in Women: Cardiovascular Risk Across the Lifespan
Heart Matters
Hypertension in Women: Cardiovascular Risk Across the Lifespan
Shelina Ramnarine, PhD; Payal Kohli, MD, FACC
- Shelina Ramnarine, PhD
- Payal Kohli, MD, FACC
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Clinician's Roundtable
Multi-Omics Brings New Clarity to the REHAB-PH Trial
PiB PET Uncovers Hidden ATTR-CM
PiB PET Uncovers Hidden ATTR-CM
Heart Matters
PiB PET Uncovers Hidden ATTR-CM
Recognizing ATTR-CM in High-Risk Populations
Recognizing ATTR-CM in High-Risk Populations
On the Frontlines of ATTR-CM
Recognizing ATTR-CM in High-Risk Populations
Steve Jackson, PharmD; Frederick Ruberg, MD
- Steve Jackson, PharmD
- Frederick Ruberg, MD
Recognizing and Managing Swelling in ATTR-CM
Recognizing and Managing Swelling in ATTR-CM
On the Frontlines of ATTR-CM
Recognizing and Managing Swelling in ATTR-CM
Steve Jackson, PharmD; Kevin S. Shah, MD
- Steve Jackson, PharmD
- Kevin S. Shah, MD
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
On the Frontlines of ATTR-CM
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
Shelina Ramnarine, PhD; Valmiki Maharaj, MD
- Shelina Ramnarine, PhD
- Valmiki Maharaj, MD
Efficacy and Safety of Finerenone in Patients With Non-Diabetic CKD: Insight From FIND-CKD
Efficacy and Safety of Finerenone in Patients With Non-Diabetic CKD: Insight From FIND-CKD
Nephrology
Efficacy and Safety of Finerenone in Patients With Non-Diabetic CKD: Insight From FIND-CKD
prof. Hiddo Heerspink
- prof. Hiddo Heerspink

Clinical Practice

Macitentan in Pediatric PAH: Results from the TOMORROW Trial
Macitentan in Pediatric PAH: Results from the TOMORROW Trial
Clinician's Roundtable
Macitentan in Pediatric PAH: Results from the TOMORROW Trial
Recognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
Recognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
Heart Matters
Recognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
CME/CE
Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
Muthiah Vaduganathan, MD, MPH; Koichiro Kinugawa, MD
0.25 credits
- Muthiah Vaduganathan, MD, MPH
- Koichiro Kinugawa, MD
- Michael Böhm, MD
0.25 credits
Understanding the Mechanisms Behind Resistant Hypertension
Understanding the Mechanisms Behind Resistant Hypertension
Heart Matters
Understanding the Mechanisms Behind Resistant Hypertension
Steve Jackson, PharmD; Jan Basile, MD
- Steve Jackson, PharmD
- Jan Basile, MD
- Michael J. Bloch, MD, FAHA, FASH, FNLA, FSVM, FACP
Leadoff Hitter – Spotting High-Risk Players
Leadoff Hitter – Spotting High-Risk Players
MinuteCE®
Leadoff Hitter – Spotting High-Risk Players
J.A. Randy Englert, MD, FACC
0.75 program credits
- J.A. Randy Englert, MD, FACC
0.75 program credits
Swing for the Fences – LDL-C as the Power Hitter
Swing for the Fences – LDL-C as the Power Hitter
MinuteCE®
Swing for the Fences – LDL-C as the Power Hitter
J.A. Randy Englert, MD, FACC; Matthew Malachowski, Pharm. D., MHA
0.75 program credits
- J.A. Randy Englert, MD, FACC
- Matthew Malachowski, Pharm. D., MHA
0.75 program credits
Extra Innings – Sustaining Victory Beyond the First Game
Extra Innings – Sustaining Victory Beyond the First Game
MinuteCE®
Extra Innings – Sustaining Victory Beyond the First Game
J.A. Randy Englert, MD, FACC; Matthew Malachowski, Pharm. D., MHA
0.75 program credits
- J.A. Randy Englert, MD, FACC
- Matthew Malachowski, Pharm. D., MHA
0.75 program credits
MinuteCE®
ASCVD Playbook | Closing the Gaps, One Inning at a Time
J.A. Randy Englert, MD, FACC; Matthew Malachowski, Pharm. D., MHA
0.75 credits 6 episodes
- J.A. Randy Englert, MD, FACC
- Matthew Malachowski, Pharm. D., MHA
0.75 credits 6 episodes

CME

Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
CME/CE
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD; Julio Núñez, MD, PhD
0.25 credits
- Patrick Rossignol, MD, PhD
- Julio Núñez, MD, PhD
0.25 credits
Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
CME/CE
Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
Maria Pabon, MD; Robert J. Mentz, MD, FHFSA, FACC
0.25 credits
- Maria Pabon, MD
- Robert J. Mentz, MD, FHFSA, FACC
0.25 credits
GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
MinuteCE®
GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
Javed Butler, MD; Carolyn S. P. Lam, MBBS, PhD
0.75 program credits
- Javed Butler, MD
- Carolyn S. P. Lam, MBBS, PhD
0.75 program credits
MinuteCE®
The Ambulatory HFrEF Blind Spot: Proactively Reducing CV Mortality Risk Despite Optimized GDMT
Javed Butler, MD; Prof. Dr. Johann Bauersachs
0.75 credits 5 episodes
- Javed Butler, MD
- Prof. Dr. Johann Bauersachs
- Carolyn S. P. Lam, MBBS, PhD
0.75 credits 5 episodes
Missing the Window in Ambulatory Patients With HFrEF on GDMT: Strategies for CV Risk Reduction
Missing the Window in Ambulatory Patients With HFrEF on GDMT: Strategies for CV Risk Reduction
CME/CE
Missing the Window in Ambulatory Patients With HFrEF on GDMT: Strategies for CV Risk Reduction
Stephen J. Greene, MD, FACC, FHFSA; Gianluigi Savarese, MD, PhD, FESC, FHFA
0.25 credits
- Stephen J. Greene, MD, FACC, FHFSA
- Gianluigi Savarese, MD, PhD, FESC, FHFA
0.25 credits
Earlier Action, Lasting Impact: Closing the LDL-C Gap in Patients Without a Prior MACE
Earlier Action, Lasting Impact: Closing the LDL-C Gap in Patients Without a Prior MACE
CME/CE
Earlier Action, Lasting Impact: Closing the LDL-C Gap in Patients Without a Prior MACE
Erin Bohula, MD, DPhil; Lawrence Leiter
0.25 credits
- Erin Bohula, MD, DPhil
- Lawrence Leiter
0.25 credits
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
CME/CE
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
Scott Solomon, MD
0.25 credits
- Scott Solomon, MD
0.25 credits
The Fifth Pillar? Closing the Gap in HFrEF
The Fifth Pillar? Closing the Gap in HFrEF
CME/CE
The Fifth Pillar? Closing the Gap in HFrEF
Carolyn S. P. Lam, MBBS, PhD; Javed Butler, MD
0.50 credits
- Carolyn S. P. Lam, MBBS, PhD
- Javed Butler, MD
- Stephen J. Greene, MD, FACC, FHFSA
0.50 credits

Medical News

Medical News
Beta-Blocker Continuation Linked to More Heart Transplants
07/30/2026
Read more
Medical News
ACTN2 Variants in HCM Show Distinct Protein Effects
07/28/2026
Read more
Medical News
Heart Transplant Disparities Tied to Center-Level Decisions
07/28/2026
Read more
Medical News
Weight Loss Trial in Older Adults with Persistent Atrial Fibrillation
07/27/2026
Read more
Medical News
Food Supplementation After Heart Failure Hospitalization
07/27/2026
Read more
Medical News
Cardiac Rehabilitation Lowers Risk in Rheumatoid Arthritis with Hypertension
07/27/2026
Read more
Medical News
Commercial Cardiology Prices Varied Widely Across US Insurers
07/27/2026
Read more
Medical News
0/1-Hour vs 0/3-Hour Troponin Pathways in Suspected ACS
07/27/2026
Read more